Icatibant
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Icatibant is a prescription medication used to treat acute attacks of hereditary angioedema, a rare genetic disorder causing swelling in the skin, airways, or intestines. It works by blocking bradykinin, a substance that triggers swelling. Administered as a subcutaneous injection (under the skin), each dose contains 30 mg of icatibant acetate in a 3 mL syringe. Manufactured by Alembic Pharmaceuticals, it's available in packs of 1 or 3 syringes. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Icatibant
Access the FDA dataset for Icatibant β ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025